Has Arterial Revascularization Trial [ART] burst the BITA bubble?
Pradeep NarayanPublished in: Indian journal of thoracic and cardiovascular surgery (2019)
The 10-year outcome of the Arterial Revascularization Trial (ART) has recently been published. The study is the largest randomized study comparing bilateral internal thoracic artery (BITA) with single internal thoracic artery (SITA) as a grafting strategy for coronary artery bypass. In this review, a critical appraisal of the study has been performed where the result of the trial has been discussed along with the risk of sternal wound infections, the presence of a learning curve, and the influence of volume on outcomes. The influence of BITA grafting on other aspects like influence on hospital stay and quality of life outcomes has also been discussed.
Keyphrases
- study protocol
- percutaneous coronary intervention
- clinical trial
- phase iii
- coronary artery bypass
- phase ii
- spinal cord
- randomized controlled trial
- healthcare
- coronary artery bypass grafting
- emergency department
- antiretroviral therapy
- type diabetes
- systematic review
- acute coronary syndrome
- spinal cord injury
- skeletal muscle
- adverse drug
- case report
- atrial fibrillation
- acute care